Ninety one (91) % of SSc-ILD patients had positive ATA (vs. 33% of SSc-non-ILD patients, p = 0.0007), while ACA were significantly less frequent in SSc-ILD patients as opposed to those without ILD (4 vs. 42%, p = 0.007). This evidence concerns the gene ATM and interstitial lung disease.